BioCentury
ARTICLE | Clinical News

CVBT-141B: Phase I data

October 8, 2007 7:00 AM UTC

In a Phase I trial in 8 patients with either diabetic or venous stasis ulcers, topical CVBT-141B was well tolerated. ...